Cost of investigations during the acute hospital stay following total hip or knee arthroplasty, by complication status.
Complications
Cost
Imaging
Investigations
Pathology
Post-operative complications
Total hip arthroplasty
Total knee arthroplasty
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
12 Nov 2020
12 Nov 2020
Historique:
received:
11
02
2020
accepted:
02
11
2020
entrez:
13
11
2020
pubmed:
14
11
2020
medline:
10
4
2021
Statut:
epublish
Résumé
Total hip and total knee arthroplasties are among the most common types of surgery performed in Australia today and are effective treatments for severe osteoarthritis. However, the increasing financial burden on the health system owing to the increasing rates of surgery has led to a growing interest in improving the cost-effectiveness and safety of arthroplasty care. This study was designed to quantify the association between post-operative complications, a major cost driver, and the cost of investigations following total hip or knee arthroplasty. This is a prospective cohort study of consecutive patients undergoing primary total hip or knee arthroplasty at an Australian public hospital. We measured the number and cost of imaging and pathology tests performed during the acute hospital stay and used linear regression to quantify the association between complication status and investigation costs. Five hundred patients were included in the analysis. On average, those with complications received more tests, and more expensive tests. The mean combined cost of imaging and pathology tests in patients with no complications was AU$ 187 (SD: 12.0). In comparison, patients with minor complications had a mean additional cost of AU$ 270 (SD: 31.0), and those with major complications had a mean additional cost of AU$ 493 (SD: 54.2) (p < 0.001). In patients undergoing hip or knee arthroplasty, investigation costs are substantially greater in the presence of either minor or major complications. With growing volumes of total hip and total knee arthroplasties, a potential focus of future research could include optimising investigation practices for patients with and without complications.
Sections du résumé
BACKGROUND
BACKGROUND
Total hip and total knee arthroplasties are among the most common types of surgery performed in Australia today and are effective treatments for severe osteoarthritis. However, the increasing financial burden on the health system owing to the increasing rates of surgery has led to a growing interest in improving the cost-effectiveness and safety of arthroplasty care. This study was designed to quantify the association between post-operative complications, a major cost driver, and the cost of investigations following total hip or knee arthroplasty.
METHODS
METHODS
This is a prospective cohort study of consecutive patients undergoing primary total hip or knee arthroplasty at an Australian public hospital. We measured the number and cost of imaging and pathology tests performed during the acute hospital stay and used linear regression to quantify the association between complication status and investigation costs.
RESULTS
RESULTS
Five hundred patients were included in the analysis. On average, those with complications received more tests, and more expensive tests. The mean combined cost of imaging and pathology tests in patients with no complications was AU$ 187 (SD: 12.0). In comparison, patients with minor complications had a mean additional cost of AU$ 270 (SD: 31.0), and those with major complications had a mean additional cost of AU$ 493 (SD: 54.2) (p < 0.001).
CONCLUSIONS
CONCLUSIONS
In patients undergoing hip or knee arthroplasty, investigation costs are substantially greater in the presence of either minor or major complications. With growing volumes of total hip and total knee arthroplasties, a potential focus of future research could include optimising investigation practices for patients with and without complications.
Identifiants
pubmed: 33183328
doi: 10.1186/s12913-020-05892-1
pii: 10.1186/s12913-020-05892-1
pmc: PMC7659097
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1036Références
Clin Orthop Relat Res. 2017 Dec;475(12):2926-2937
pubmed: 28108823
J Arthroplasty. 2016 Jan;31(1):42-8
pubmed: 26318081
J Arthroplasty. 2012 Jun;27(6):1051-6
pubmed: 22305435
J Arthroplasty. 2011 Dec;26(8):1404-8
pubmed: 21477972
Bone Joint J. 2019 Jan;101-B(1_Supple_A):25-31
pubmed: 30648494
Arch Surg. 2002 May;137(5):611-7; discussion 617-8
pubmed: 11982478
Nephrol Dial Transplant. 2015 Aug;30(8):1244-9
pubmed: 25813274
BMC Musculoskelet Disord. 2019 Feb 23;20(1):90
pubmed: 30797228
J Arthroplasty. 2020 Oct;35(10):2892-2898
pubmed: 32466996
BMJ. 2000 Apr 29;320(7243):1197-200
pubmed: 10784550
J Arthroplasty. 2019 Jul;34(7S):S168-S172
pubmed: 30948289
J Arthroplasty. 2018 Sep;33(9):2752-2758
pubmed: 29858101
Clin Orthop Relat Res. 2015 May;473(5):1574-81
pubmed: 24706043
J Arthroplasty. 2015 Jan;30(1):19-25
pubmed: 25294788
Arthritis Care Res (Hoboken). 2015 May;67(6):782-90
pubmed: 25470687
Anesthesiology. 2012 Jul;117(1):107-16
pubmed: 22634871
J Orthop. 2013 Jul 30;10(3):115-8
pubmed: 24396226
J Arthroplasty. 2019 Mar;34(3):538-541
pubmed: 30559010